Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (NCT05800951)
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS Study)
🩺 Plain-English Summary (8th-Grade Level)
The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom have the capability of MCS escalation on-site. Study enrollment is targeted at 120 patients at 20 hospital sites, evaluating clinical outcomes, and focusing on outcomes MCS escalation decision making and ICU level management.
Who can join: Review the eligibility criteria below.
Location: Loma Linda University Medical Center — Loma Linda, California
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (17 Sites)
- Loma Linda University Medical Center — Loma Linda, California
- Ronald Reagan UCLA Medical Center — Los Angeles, California
- Providence St. Joseph Hospital Orange — Orange, California
- St. Anthony Hospital — Lakewood, Colorado
- George Washington University Hospital — Washington D.C., District of Columbia
- Northside Hospital Atlanta — Atlanta, Georgia
- St. Elizabeth Edgewood Hospital — Edgewood, Kentucky
- Henry Ford Hospital — Detroit, Michigan
- Ascenion St. John Hospital — Detroit, Michigan
- Spectrum Health Hospitals Fred and Lena Meijer Heart Center — Grand Rapids, Michigan
- Hackensack Meridian Jersey Shore University Medical Center — Neptune City, New Jersey
- Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania
- Fort Sanders Regional Medical Center — Knoxville, Tennessee
- TriStar Centennial Medical Center — Nashville, Tennessee
- Parkwest Medical Center — Nashville, Tennessee
- Methodist Hospital — San Antonio, Texas
- UVA University Hospital — Charlottesville, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiogenic Shock
- A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C — Boston, Massachusetts
- Augmented Pacing for Shock in the Cardiac Intensive Care Unit — Nashville, Tennessee
- CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock — Boston, Massachusetts
- Intra-aortic Balloon Counterpulsation (IABC) Compliance — Philadelphia, Pennsylvania
- Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial — Falls Church, Virginia
Explore by condition: All Cardiogenic Shock clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.